Search Results
Results found for "David E Gloriam"
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Burger , Arthur Christopoulos , David M.
- Unlocking the Future of Medicine: Advancements in GPCR Research
reveals unexpected differences in downstream pathway activation Chiara D Mancinelli, Joshua Levitz, David
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
José Labandeira-García , Rafael Franco Endomembrane GPCR signaling: 15 years on, the quest continues Davide
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
E. Cardona et al. 2008). E. Cardona et al. 2008).
- Fluorescence Polarization in GPCR Research
Gioé-Gallo C, Mallo-Abreu A, Brea J, Loza MI, García-Rey A, García-Mera X, Gutiérrez-de-Terán H, Sotelo E.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
This Week’s Highlights: G protein-coupled receptor (GPCR) pharmacogenomics Miles D Thompson , David
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Working closely with Professor David Parker of Durham University, Trinquet’s group cracked the scaffold
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
B., Mehrota, E., Grimes, P. R., ... & Manglik, A. (2024).
- Ode to GPCRs
Physiology or Medicine was awarded jointly to Ragnar Arthur Granit, Haldan Keffer Hartline, and George David E. Nobel Prize: Three Named for Medicine, Physiology Award. Ekaterini Tiligada, C., Tiligada, E. & Ennis, M.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Curr Issues Mol Biol. 2024 Oct 19;46(10):11646-11664. doi: 10.3390/cimb46100691 Navarro G, Sotelo E,
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Structure-guided design of a peripherally restricted chemogenetic system Hye Jin Kang , Brian E Krumm
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
molecular dynamics simulations Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB4) and E
- 📰 GPCR Weekly News, November 13 to 19, 2023
Encoded Fluorescent Indicators Design of an effective small expression tag to enhance GPCR production in E.
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A. M., Trinidad, D. D., English, J.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Goyet, E., et al., Fast and high resolution single-cell BRET imaging.
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Reiter, E., Ahn, S., Shukla, A.K., and Lefkowitz, R.J. (2012).
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
GPCRs are divided into six classes based on amino acid sequence similarities, but only four of the classes
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
Gq, Gs, Gi, G12 and G13 engagements with GPR110 reveals details of G-protein engagement, including a dividing
- Glyco-sulfo hotspots in the chemokine receptor system
affects the recognition of CCL21 but not CCL19, interfering with dendritic cell trafficking (Kiermaier E
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
This may be broadly divided into studies focused on obtaining detailed molecular information in the intracellular
- Conjugation Strategies for Probe Development
Thanks to the unique linker structure we obtain, which can be divided into three differentiated parts
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Wodak SJ, Paci E, Dokholyan NV, Berezovsky IN, Horovitz A, Li J, et al. Pearce A, Redfern-Nichols T, Wills E, Rosa M, Manulak I, Sisk C, et al.
- From Failed Experiments to Predictive GPCR Models
former students now work in industry, where their ability to bridge the computational-experimental divide
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Methods: Rats were divided into sham, sham + Exendin-4 (10 μg/day, i.p), MI, and MI + Exendin-4.
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
The cytotoxic drug Monomethyl auristatin E (MMAE) was used alone or conjugated to either the native CCL5
















